Sign In
Buy RNA
Avidity Biosciences Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -76.03. In total, the insiders bought 930.67K and sold 596.87K RNA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-76.03 |
| ● Buy | 930.67K shares |
| ● Sell | 596.87K shares |
|
47% Buy Activity
Weak Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 21, 2026 Sell |
Mccarthy Teresa Chief Human Resources Officer |
1 453 Value: $105.3K |
||
|
Jan 21, 2026 Sell |
Mccarthy Teresa Chief Human Resources Officer |
1 476 Value: $106.9K |
||
|
Jan 21, 2026 Sell |
Flanagan W. Michael Chief Scientific Officer |
3 976 Value: $288.1K |
||
|
Jan 21, 2026 Sell |
Boyce Sarah President And CEO |
7 993 Value: $579.1K |
||
|
Jan 21, 2026 Sell |
Boyce Sarah President And CEO |
6 394 Value: $463.2K |
||
|
Jan 21, 2026 Sell |
Hughes Steven George Chief Medical Officer |
2 017 Value: $146.1K |
||
|
Jan 21, 2026 Sell |
Flanagan W. Michael Chief Scientific Officer |
2 558 Value: $185.3K |
||
|
Jan 21, 2026 Sell |
Hughes Steven George Chief Medical Officer |
2 878 Value: $208.5K |
||
|
Jan 21, 2026 Sell |
Maclean Michael F Chief Financial Officer |
1 807 Value: $130.9K |
||
|
Jan 21, 2026 Sell |
Maclean Michael F Chief Financial Officer |
2 735 Value: $198.2K |
||
|
Jan 21, 2026 Sell |
Levin Arthur A Director |
1 758 Value: $127.4K |
||
|
Jan 07, 2026 Sell |
Maclean Michael F Chief Financial Officer |
1 974 Value: $142.6K |
||
|
Jan 07, 2026 Sell |
Mccarthy Teresa Chief Human Resources Officer |
1 965 Value: $141.9K |
||
|
Jan 07, 2026 Sell |
Boyce Sarah President And CEO |
8 576 Value: $619.4K |
||
|
Jan 07, 2026 Sell |
Calderaro Charles Iii Chief Technical Officer |
3 727 Value: $269.2K |
||
|
Jan 07, 2026 Sell |
Moriarty John B Chief Legal Officer |
2 374 Value: $171.5K |
||
|
Jan 07, 2026 Sell |
Hughes Steven George Chief Medical Officer |
2 373 Value: $171.4K |
||
|
Jan 07, 2026 Sell |
Flanagan W. Michael Chief Scientific Officer |
2 373 Value: $171.4K |
||
|
Dec 19, 2025 Sell |
Levin Arthur A Director |
1 330 Value: $0 |
||
|
Dec 18, 2025 Sell |
Boyce Sarah President And CEO |
29 159 Value: $0 |
||
|
Dec 17, 2025 Sell |
Mccarthy Teresa Chief Human Resources Officer |
17 298 Value: $1.24M |
||
|
Dec 17, 2025 Sell |
Gallagher Kathleen P. Chief Program Officer |
8 030 Value: $577.1K |
||
|
Dec 17, 2025 Sell |
Moriarty John B Chief Legal Officer |
26 824 Value: $1.93M |
||
|
Dec 17, 2025 Buy |
Boyce Sarah President And CEO |
31 000 Value: $2.23M |
||
|
Dec 17, 2025 Buy |
Mosbrooker Eric Chief Commercial Officer |
72 000 Value: $5.17M |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
